Antiplatelet drugs lower the risk of pre-eclampsia
Previous reviews have concluded that antiplatelets are not effective in
reducing risks of pre-eclampsia. Duley et al (p 329) report a
systematic review including data from over 30 000 women in 39 studies.
Antiplatelet drugs were associated with a 15% reduction in the risk of
pre-eclampsia, a 14% reduction in the risk of a stillbirth or neonatal
death, and an 8% reduction in the risk of preterm birth. Further
research is needed to clarify which women benefit most and when
treatment should be started.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
StumbleUpon 
Technorati What's this?
Relevant Article
- Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review
- Lelia Duley, David Henderson-Smart, Marian Knight, and James King
BMJ 2001 322: 329-333.[Abstract] [Full Text] [PDF]
This Article
- Respond to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
Related Content
Bookmark with
What's new
Latest blogs
Find BMJ on:
Services
Tools
Online poll
Resources
Rapid responses for this article
There are no rapid responses for this article. Print issues
